A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.

Cancers (Basel) · 2022 · PMC9221477 · PMID 35740637

Europe PMC DOI

hedged sentence

0.1370

closest p · 2.7× alpha

0.1370

boldest claim

The sentences

did not reach statistical significancep = 0.137not close (p > 0.1)

Exon 19 deletions tended to be more frequent in early versus advanced stage (51.4% and 39%, respectively), although this difference did not reach statistical significance ( p = 0.137).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.